Invitrogen, PerkinElmer, MaxCyte, Nikon Instruments, Thorlabs | GenomeWeb
Invitrogen this week announced the launch of the Premo halide sensor, a pharmacologically relevant sensor for functional studies of ligand- and voltage-gated chloride channels.
 
The sensor is based on a halide-sensitive form of Venus, the brightest available yellow fluorescent protein, according to the company. Users introduce the Premo halide sensor into cells of interest 24 hours ahead of the assay via BacMam technology, add iodide-containing buffer to the culture, and then add test compounds.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.